These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 27475264)

  • 1. The Iowa Gambling Task in Parkinson's disease: A meta-analysis on effects of disease and medication.
    Evens R; Hoefler M; Biber K; Lueken U
    Neuropsychologia; 2016 Oct; 91():163-172. PubMed ID: 27475264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iowa gambling task impairment in Parkinson's disease can be normalised by reduction of dopaminergic medication after subthalamic stimulation.
    Castrioto A; Funkiewiez A; Debû B; Cools R; Lhommée E; Ardouin C; Fraix V; Chabardès S; Robbins TW; Pollak P; Krack P
    J Neurol Neurosurg Psychiatry; 2015 Feb; 86(2):186-90. PubMed ID: 24860137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applied strategy in the Iowa Gambling Task: Comparison of individuals with Parkinson's disease to healthy controls.
    Kjær SW; Callesen MB; Larsen L; Borghammer P; Østergaard K; Damholdt MF
    J Clin Exp Neuropsychol; 2020 Jul; 42(5):425-435. PubMed ID: 32283989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parkinson's disease duration determines effect of dopaminergic therapy on ventral striatum function.
    MacDonald AA; Monchi O; Seergobin KN; Ganjavi H; Tamjeedi R; MacDonald PA
    Mov Disord; 2013 Feb; 28(2):153-60. PubMed ID: 23165957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iowa gambling task in Parkinson's disease.
    Poletti M; Cavedini P; Bonuccelli U
    J Clin Exp Neuropsychol; 2011 Apr; 33(4):395-409. PubMed ID: 21140314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective IGT decision-making impairment in a patient with juvenile Parkinson's disease and pathological gambling: a role for dopaminergic therapy?
    Pignatti R; Brioschi A; Mauro A; Zamarian L; Wenter J; Semenza C
    Neurocase; 2012; 18(6):503-13. PubMed ID: 22224448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different effects of dopaminergic medication on perceptual decision-making in Parkinson's disease as a function of task difficulty and speed-accuracy instructions.
    Huang YT; Georgiev D; Foltynie T; Limousin P; Speekenbrink M; Jahanshahi M
    Neuropsychologia; 2015 Aug; 75():577-87. PubMed ID: 26184442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissociation of decision-making under ambiguity and decision-making under risk in patients with Parkinson's disease: a neuropsychological and psychophysiological study.
    Euteneuer F; Schaefer F; Stuermer R; Boucsein W; Timmermann L; Barbe MT; Ebersbach G; Otto J; Kessler J; Kalbe E
    Neuropsychologia; 2009 Nov; 47(13):2882-90. PubMed ID: 19545579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decision-making in Parkinson's disease patients with and without pathological gambling.
    Rossi M; Gerschcovich ER; de Achaval D; Perez-Lloret S; Cerquetti D; Cammarota A; Inés Nouzeilles M; Fahrer R; Merello M; Leiguarda R
    Eur J Neurol; 2010 Jan; 17(1):97-102. PubMed ID: 19780806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopaminergic medication counteracts conflict adaptation in patients with Parkinson's disease.
    Duthoo W; Braem S; Houtman F; Schouppe N; Santens P; Notebaert W
    Neuropsychology; 2013 Sep; 27(5):556-61. PubMed ID: 23815093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of dopaminergic medication on dynamic decision making in Parkinson's disease.
    Osman M; Ryterska A; Karimi K; Tu L; Obeso I; Speekenbrink M; Jahanshahi M
    Neuropsychologia; 2014 Jan; 53():157-64. PubMed ID: 24269857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the role of dopamine replacement therapy in decision-making, working memory, and reward in Parkinson's disease: does the therapy-dose matter?
    Torta DM; Castelli L; Zibetti M; Lopiano L; Geminiani G
    Brain Cogn; 2009 Nov; 71(2):84-91. PubMed ID: 19442427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of dopaminergic medication on conflict adaptation in Parkinson's disease.
    Ruitenberg MFL; Abrahamse EL; Santens P; Notebaert W
    J Neuropsychol; 2019 Mar; 13(1):121-135. PubMed ID: 28714199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine asymmetry interacts with medication to affect cognition in Parkinson's disease.
    Tomer R; Aharon-Peretz J; Tsitrinbaum Z
    Neuropsychologia; 2007 Jan; 45(2):357-67. PubMed ID: 16876208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levodopa medication improves incidental sequence learning in Parkinson's disease.
    Beigi M; Wilkinson L; Gobet F; Parton A; Jahanshahi M
    Neuropsychologia; 2016 Dec; 93(Pt A):53-60. PubMed ID: 27686948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopaminergic effects on cognitive performance in patients with Parkinson's disease.
    Lange KW; Paul GM; Naumann M; Gsell W
    J Neural Transm Suppl; 1995; 46():423-32. PubMed ID: 8821078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decisions under risk in Parkinson's disease: preserved evaluation of probability and magnitude.
    Sharp ME; Viswanathan J; McKeown MJ; Appel-Cresswell S; Stoessl AJ; Barton JJ
    Neuropsychologia; 2013 Nov; 51(13):2679-89. PubMed ID: 23954375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic dopaminergic stimulation in Parkinson's disease: from dyskinesias to impulse control disorders.
    Voon V; Fernagut PO; Wickens J; Baunez C; Rodriguez M; Pavon N; Juncos JL; Obeso JA; Bezard E
    Lancet Neurol; 2009 Dec; 8(12):1140-9. PubMed ID: 19909912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathological gambling in two patients on dopamine replacement therapy for Parkinson's disease.
    Avanzi M; Uber E; Bonfà F
    Neurol Sci; 2004 Jun; 25(2):98-101. PubMed ID: 15221629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pathological gambling behavior in a patient with Parkinson's disease treated with levodopa and bromocriptine].
    Montastruc JL; Schmitt L; Bagheri H
    Rev Neurol (Paris); 2003 Apr; 159(4):441-3. PubMed ID: 12773874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.